|
|
Haorui supplies
Amifostine API
(Active Pharmaceutical Ingredient) to pharmaceutical
industry.
Haorui's
Amifostine API
is produced by
FDA approved cGMP facilities,
we supply Amifostine API from small
R&D to large commercial quantity. For product and supply
details please contact us. |
|
Amifostine
Patents 3 |
|
Amifostine Clinical Trials 1
Amifostine Clinical Trials 2 |
|
Amifostine Patents 1
Amifostine Patents 2
Amifostine Patents 3 |
|
Amifostine Patents 4
Amifostine Patents 5 |
| 101 |
7,071,335 |
2-pyridinyl-1-piperazine therapeutic agents useful
for treating pain |
| 102 |
7,067,249 |
Inhibition of hepatitis B virus (HBV) replication by
RNA interference |
| 103 |
7,067,159 |
Methods for treating prostate cancer with herbal
compositions |
| 104 |
7,060,708 |
Active agent delivery systems and methods for
protecting and administering active agents |
| 105 |
7,056,897 |
Inducible expression vectors and methods of use
thereof |
| 106 |
7,056,339 |
Drug delivery platform
|
| 107 |
7,053,150 |
Segmented polymers and their conjugates
|
| 108 |
7,053,072 |
Methods for the administration of amifostine and
related compounds |
| 109 |
7,048,939 |
Methods for the inhibition of neointima formation
|
| 110 |
7,045,550 |
Polyamines and analogs for protecting cells during
cancer chemotherapy and radiotherapy |
| 111 |
7,041,668 |
Substituted benzimidazole compounds and their use
for the treatment of cancer |
| 112 |
7,041,292 |
Treating prostate cancer with anti-ErbB2 antibodies
|
| 113 |
7,034,052 |
7-Amido-isoindolyl compounds and their
pharmaceutical uses |
| 114 |
7,029,916 |
Apparatus and method for flow electroporation of
biological samples |
| 115 |
7,022,315 |
Administration of a thiol-based chemoprotectant
compound |
| 116 |
7,005,450 |
2-amino-2-alkyl-4 hexenoic and hexynoic acid
derivatives useful as nitric oxide synthase
inhibitors |
| 117 |
6,995,175 |
Chemical derivatives and their application as
antitelomerase agent |
| 118 |
6,995,168 |
Triazaspiro compounds useful for treating or
preventing pain |
| 119 |
6,995,162 |
Substituted alkylamine derivatives and methods of
use |
| 120 |
6,992,094 |
Diarylselenide compounds and their use in human or
veterinary medicine and in cosmetics |
| 121 |
6,984,619 |
Method for protection against tumor metastasis
formation |
| 122 |
6,984,389 |
Using heat shock proteins to improve the therapeutic
benefit of a non-vaccine treatment modality
|
| 123 |
6,974,818 |
1,2,5-thiadiazol-3-YL-piperazine therapeutic agents
useful for treating pain |
| 124 |
6,962,940 |
(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoiso
indoline-1,3-dione: methods of using and
compositions thereof |
| 125 |
6,960,594 |
Thiophene and furan 2,5-dicarboxamides useful in the
treatment of cancer |
| 126 |
6,958,148 |
Linkage of agents to body tissue using
microparticles and transglutaminase |
| 127 |
6,951,889 |
2-amino-2-alkyl-5 heptenoic and heptynoic acid
derivatives useful as nitric oxide synthase
inhibitors |
| 128 |
6,951,876 |
Sulfamoylheteroaryl pyrazole compounds as
anti-inflammatory/analgesic agents |
| 129 |
6,949,536 |
Sulfonylbenzene compounds as
anti-inflammatory/analgesic agents |
| 130 |
6,949,514 |
Anti-tumor agents
|
| 131 |
6,949,245 |
Humanized anti-ErbB2 antibodies and treatment with
anti-ErbB2 antibodies |
| 132 |
6,939,874 |
Substituted pyrimidinyl derivatives and methods of
use |
| 133 |
6,927,036 |
Methods for synthesis of prodrugs from 1-acyl-alkyl
derivatives and compositions thereof |
| 134 |
6,923,988 |
Solid carriers for improved delivery of active
ingredients in pharmaceutical compositions |
| 135 |
6,919,076 |
Conjugates of agents and transglutaminase substrate
linking molecules |
| 136 |
6,914,158 |
Amidino compounds useful as nitric oxide synthase
inhibitors |
| 137 |
6,911,464 |
N-alkyl-hydroxamic acid-isoindolyl compounds and
their pharmaceutical uses |
| 138 |
6,911,306 |
TMS1 compositions and methods of use
|
| 139 |
6,906,098 |
Mixed steroidal 1,2,4,5-tetraoxane compounds and
methods of making and using thereof |
| 140 |
6,906,091 |
Method of cancer treatment
|
| 141 |
6,890,904 |
Anti-tumor agents
|
| 142 |
6,887,904 |
Substituted arylcycloalkanes, compositions
containing them and use thereof |
| 143 |
6,887,873 |
Triazine derivatives and their application as
antitelomerase agents |
| 144 |
6,881,737 |
Substituted triazinyl acrylamide derivatives and
methods of use |
| 145 |
6,878,714 |
Substituted alkylamine derivatives and methods of
use |
| 146 |
6,872,733 |
Benzimidazolone compounds
|
| 147 |
6,867,222 |
Nociceptin analogs
|
| 148 |
6,864,261 |
Therapeutic agents useful for treating pain
|
| 149 |
6,864,255 |
Substituted triazinyl amide derivatives and methods
of use |
| 150 |
6,861,421 |
Nociceptin analogs
|
|
|
